---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-023053"
form_type: "8-K"
ticker: "BLFS"
cik: "0000834365"
company_name: "BIOLIFE SOLUTIONS INC"
filed_at: "2022-09-26T23:59:59+00:00"
generated_at: "2026-06-23T07:35:07.697731+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioLife Solutions enters up to $40M term loan facility with Silicon Valley Bank

## Summary
- Term loans up to $40M total; $10M conditional on achieving revenue milestones by June 30, 2023.
- Interest at greater of 5.75% or Prime plus 0.50% per annum; cap on rate increase of 1% above funding date rate.
- Principal repaid in 24 equal monthly installments starting July 1, 2024 (extendable to July 1, 2025); maturity June 1, 2026 (extendable to 2027).
- Prepayment penalty 2% in first year, 1% thereafter; final fee of 5.75% of aggregate principal.
- Security interest on all assets except intellectual property; subsidiaries SAVSU, Arctic Solutions, SciSafe, Global Cooling, Sexton Biotechnologies are co-borrowers.

## SEC filing metadata
- accession: 0001437749-22-023053
- form_type: 8-K
- ticker: BLFS
- cik: 0000834365
- company_name: BIOLIFE SOLUTIONS INC
- filed_at: 2022-09-26T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/834365/000143774922023053/0001437749-22-023053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/834365/000143774922023053/bioli20220923_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-023053
- JSON: https://secwatch.observer/filing/0001437749-22-023053.json
- Plain text: https://secwatch.observer/filing/0001437749-22-023053.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.